Workflow
新宙邦(300037) - 2024 Q3 - 季度财报
CAPCHEMCAPCHEM(SZ:300037)2024-10-28 08:08

Financial Performance - The company's revenue for Q3 2024 was ¥2,084,565,483.67, a decrease of 3.02% compared to the same period last year[3]. - Net profit attributable to shareholders for Q3 2024 was ¥285,666,592.04, an increase of 1.89% year-on-year[3]. - The basic earnings per share for Q3 2024 was ¥0.38, unchanged from the previous year[3]. - Net profit decreased by 12.36% to ¥707,213,372.45, influenced by the aforementioned factors[10]. - Total operating revenue for the current period reached ¥5,667,047,247.12, an increase of 1.52% compared to ¥5,582,582,244.24 in the previous period[26]. - Net profit for the current period was ¥707,213,372.45, a decrease of 12.34% from ¥806,913,047.48 in the previous period[27]. - Total profit for the current period was ¥824,744,790.79, a decrease of 10.61% compared to ¥922,445,683.52 in the previous period[27]. Assets and Liabilities - Total assets at the end of Q3 2024 were ¥17,142,735,791.15, a decrease of 2.73% from the end of the previous year[3]. - Current assets decreased from ¥9,514,174,302.66 to ¥7,901,026,511.73, a reduction of about 16.88%[22]. - Total liabilities decreased from ¥7,992,083,979.17 to ¥7,112,886,943.27, a decline of about 11.00%[25]. - The company's total liabilities decreased by 63.26% for non-current liabilities due within one year, amounting to ¥113,945,037.13[9]. - Shareholders' equity increased from ¥9,632,229,121.89 to ¥10,029,848,847.88, reflecting a growth of approximately 4.13%[25]. Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥706,396,116.00, down 5.16% year-on-year[3]. - Net cash flow from operating activities dropped by 107.59% to -¥189,838,352.66, mainly due to increased payable notes and extended accounts receivable periods[11]. - Net cash flow from investing activities improved by 37.34% to -¥1,337,587,871.13, attributed to reduced purchases of bank financial products and lower construction expenditures[11]. - Net cash flow from financing activities decreased by 298.70% to -¥392,928,440.69, primarily due to increased loan repayments[11]. - Total cash and cash equivalents at the end of the period were 1,022,486,449.12 CNY, down from 3,769,554,251.09 CNY at the end of the previous period[30]. Investments and Expenditures - The company reported a significant increase in development expenditures, rising by 1040.68% to ¥53,294,771.67 due to increased R&D investments[8]. - Research and development expenses were ¥274,805,356.99, down 23.87% from ¥360,941,049.81 in the previous period[26]. - The company reported a significant increase in capital reserve from ¥2,702,322,518.69 to ¥2,891,948,652.10, an increase of approximately 7.00%[25]. Shareholder Information - Total number of ordinary shareholders at the end of the reporting period was 30,443[12]. - The largest shareholder, Qin Jiusan, holds 13.63% of the shares, totaling 102,779,885 shares[12]. - The company has a total of 10 major shareholders, with the largest shareholder holding 1.77% of the total shares[15]. - The company has not released any restricted shares during the current period for its executives[16]. Other Financial Metrics - Financial expenses increased by 271.54% to ¥17,166,110.75 due to reduced interest income and increased convertible bond interest[10]. - Other income rose by 54.01% to ¥59,402,641.51, primarily from increased VAT deductions[10]. - Investment income improved significantly by 296.07% to ¥13,982,799.72, driven by higher financial management returns[10]. - The company reported a net loss from fair value changes of financial assets amounting to ¥12,996,110.35, compared to a gain of ¥10,887,842.10 in the previous period[26]. Convertible Bonds and Share Repurchase - The company has 19,694,446 convertible bonds remaining, with a total face value of RMB 1,969,444,600 as of the end of Q3 2024[17]. - The company’s convertible bond conversion price is set at RMB 41.38 per share[17]. - The company plans to repurchase shares with a total amount not less than RMB 100 million and not exceeding RMB 200 million, with a repurchase price not exceeding RMB 45 per share[18].